Synthesis and evaluation of imidazo[1,2-a]pyrazine derivatives as small molecule Gαq/11 inhibitors against uveal melanoma
- 11 June 2022
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 239, 114520
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Uveal melanomaCancer Treatment Reviews, 2012
- Imaging of Plasmodium Liver Stages to Drive Next-Generation Antimalarial Drug DiscoveryScience, 2011
- Mutations inGNA11in Uveal MelanomaNew England Journal of Medicine, 2010
- Structural basis for the specific inhibition of heterotrimeric G q protein by a small moleculeProceedings of the National Academy of Sciences, 2010
- Inhibition of Heterotrimeric G Protein Signaling by a Small Molecule Acting on Gα SubunitJournal of Biological Chemistry, 2009
- The structure and function of G-protein-coupled receptorsNature, 2009
- Frequent somatic mutations of GNAQ in uveal melanoma and blue naeviNature, 2008
- Anticancer Activity of BIM-46174, a New Inhibitor of the Heterotrimeric Gα/Gβγ Protein ComplexCancer Research, 2006
- A Novel Gαq/11-selective InhibitorJournal of Biological Chemistry, 2004
- Very Long-Term Prognosis of Patients with Malignant Uveal MelanomaInvestigative Ophthalmology & Visual Science, 2003